Author:
Nath Soumya S,Parashar Samiksha,Das Praveen K
Publisher
Jaypee Brothers Medical Publishing
Reference5 articles.
1. 1. Khilnani GC, Tiwari P, Mittal S, Kulkarni AP, Chaudhry D, Zirpe KG, et al. Guidelines for antibiotics prescription in critically-ill patients. Indian J Crit Care Med 2024. In press. DOI: 10.5005/jp-journals-10071- 24677.
2. 2. Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med 2003;31(8):2228–2237. DOI: 10.1097/01.CCM.0000087326.59341.51.
3. 3. Brismar B, Malmborg AS, Tunevall G, Wretlind B, Bergman L, Mentzing LO, et al. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrobial agents and chemotherapy 1992;36(12):2766–2773. DOI: 10.1128/aac.36.12.2766.
4. 4. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: Results of the French prospective, observational EBIIA study. Journal of Antimicrobial Chemotherapy 2009;63(4):785–794. DOI: 10.1093/jac/dkp005.
5. 5. Trienski TL, Bhanot N. Double anaerobic coverage—A call for antimicrobial stewardship. Infectious Diseases in Clinical Practice 2022;30(6):e1244. DOI: 10.1097/IPC.0000000000001244.